Antihypertensive Drugs Market Size, Share, And Trends Analysis Report By Type (ARB, CCB), By Application (Hypertension, PAH) Based On Region, And Segment Forecasts, 2022 - 2028

  • Report ID: BMRC 516 | Number of pages: 196 | Published Date: Apr 2022

    Published | Category: Healthcare | Delivery Timeline: 48 hrs

COVID-19
To know the impact of COVID-19 On Antihypertensive Drugs Market Size, Share, And Trends Analysis Report By Type (ARB, CCB), By Application (Hypertension, PAH) Based On Region, And Segment Forecasts, 2022 - 2028 Market

Request Now
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027

The Antihypertensive Drugs Market is valued at USD 24.11 Billion in 2021 and is expected to reach USD 29.35 Billion by 2028 with a CAGR of 2.85% over the forecast period.

Increasing irregular and unhealthy lifestyles are leading to hypertension and therefore, majorly driving the market growth.

Market Analysis of Antihypertensive Drugs-

Antihypertensives are a class of drugs that are used to treat high blood pressure that is hypertension. The hypertensive drugs seek to prevent the difficulties of hypertension as myocardial infarction (heart attack) and strokes. The anti-hypertension drugs are used for leveling or reducing blood pressure. Hypertension is a chronic condition, in which the blood pressure is elevated abnormally systolic as well as diastolic. This is major risk factor for causing cardiovascular, renal or endocrine disorders. The drugs comprise numerous classes of compounds with the therapeutic intention of preventing, controlling, or treating hypertension. The ultimate goal of antihypertensive drugs is to reduce cardiovascular morbidity and mortality. These are frequently used by patients and may influence the conduct of anesthesia. These drugs have diverse indications, both cardiac and non-cardiac. Comparatively, limited drug classes are used to treat hypertension, the newest among them are direct renin inhibitors. The renin-angiotensin system is targeted at different points by many of the commonly used antihypertensive drugs.

The antihypertensive Drugs market report is segmented on the basis of type, application and region & country level. Based upon type, the antihypertensive drugs market is segmented into ARB, CCB and others. Based on application, antihypertensive drugs market is segmented into hypertension, PAH and others.

Antihypertensive Drugs Market Segmentation:

By Type:

  • ARB
  • CCB
  • Others

By Application:

  • Hypertension
  • PAH
  • Others

Antihypertensive Drugs Market

Antihypertensive Drugs Market Key Players:-

Some major key players for the antihypertensive drugs market are

  • Novartis
  • Pfizer
  • Johnson & Johnson
  • Sanofi
  • Lupin
  • Ranbaxy Laboratories
  • Merck
  • Astra Zeneca
  • Daiichi Sankyo
  • Takeda
  • Actelion
  • United Therapeutics
  • JW Pharmaceutical
  • Gilead
  • CJ Healthcare
  • Bayer
  • Boryung Pharmaceutical
  • Cipla 
  • others.

Market Dynamics:-

Growing awareness about hypertension with increasing predominance, fix dose blending therapies and increased epidemic proportion of hypertension are the major factors driving the growth of global antihypertensive drugs market. In addition to this, irregular lifestyles with food habits, changes in lifestyle, aging regardless of demography and supplemented stress level are also supplementing the growth of antihypertensive drugs market. However, side effects of drugs such as; cough, diarrhea, nervousness, constipation, dizziness and weakness and increased risk of genericization may hamper the growth of market.

Moreover, increasing research and development for the novel pipeline drugs are expected more to fuel antihypertensive market in the forthcoming period. Pulmonary hypertensive practices offering training programs for people, high predominance of incessant illness, initiatives taken by government and the growing commonness of hypertension in youth population are also supporting the revenue opportunities for the antihypertensive drugs market.

Report Analysis Details
Historical data 2015 - 2020
Forecast Period 2021 - 2028
Market Size in 2021: USD 24.11 Billion
Base year considered 2020
Forecast Period CAGR %:

2.85%

Market Size Expected in 2028: USD 29.35 Billion
Tables, Charts & Figures: 175
Pages 200
Antihypertensive Drugs Companies Novartis, Pfizer, Johnson & Johnson, Sanofi, Lupin, Ranbaxy Laboratories, Merck, Astra Zeneca, Daiichi Sankyo, Takeda, Actelion, Others
Segments Covered By Type, By Application
Regional Analysis North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

 

Regional Analysis-

The antihypertensive drugs market by region is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. North America is expected to capture the largest market share owing to the high prevalence of hypertension related to renal and cardiovascular disorders in this region. Running drives by non-government and government organizations for spreading awareness among people are mostly bottling revenue generation opportunities in North America. As per the American Heart Association, under the updated guideline, more people will be diagnosed with hypertension, nearly half of American adults (46%), up from 32% under the previous definition.

Europe is expected to capture the second position due to the prevalence of cardiovascular diseases, improper diet habits, increasing obesity in children as well as in adults and high prevalence of hypertension that leads to death or disabilities in people. Asia-Pacific region will witness high growth in the antihypertensive drugs market owing to the high incidences of cardiovascular diseases, government initiatives taken for healthcare sector and high population pool.

On Antihypertensive Drugs Market Report is also available for the below Regions and Country:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherland
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest Of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest Of MEA

Key Benefits for Antihypertensive Drugs Market Report:-

  • Antihypertensive Drugs Market report covers in-depth historical and forecast analysis.
  • Antihypertensive Drugs Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, and Regional and Country levels.
  • Antihypertensive Drugs Market report helps to identify opportunities in marketplace.
  • Antihypertensive Drugs Market report covers extensive analysis of emerging trends and competitive landscape.


Frequently Asked Questions (FAQ) :
Antihypertensive Drugs Market is expected to reach USD 29.35 Billion by 2028 with a CAGR of 2.85% over the forecast period.
Antihypertensive Drugs Market is valued at USD 24.11 Billion in 2021.
North America is expected to capture the largest market share owing to the high prevalence of hypertension related to renal and cardiovascular disorders in this region.
Novartis, Pfizer, Johnson & Johnson, Sanofi, Lupin, Ranbaxy Laboratories, Merck, Astra Zeneca, Daiichi Sankyo, Takeda, Actelion, United Therapeutics, JW Pharmaceutical, Others



Interested in this report?

Antihypertensive Drugs Market Size, Share, Industry Trends analysis, Growth By 2028

report cover

Antihypertensive Drugs Market Size, Share, And Trends Analysis Report By Type (ARB, CCB), By Application (Hypertension, PAH) Based On Region, And Segment Forecasts, 2022 - 2028

Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Brandessence market research actively tracks, monitors, and analyses key industry trends in real-time via B2B surveys in 60 + countries and territories.

    Pricing


Looking for Regional Reports?